United States · Is Drug Royalty investing now?
No investments in the last 12 months.
What they do
Filed 4 private fund offerings with the SEC, the most recent in 2018-11From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Based in
- A6, United States
- Cold pitches
- Not stated
The record
No rounds observed yet. That is a limit of the sources we read, not a finding about the firm. If it has invested, a round will put it here. Know a round it was in? Tell us.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
AJAbali J. HoilettMember of Board of Managers of General PartneriFiling they signed
AHAli HedayatMember of Board of Managers of Issuer's general partner Drug Royalty III, GP, LLC(""General Partner"")iFiling they signed
ASAli SeirafiMember of Board of Mangaers of General PartneriFiling they signed
ASAndrea SotakMs. Sotak is the President and CIO of DRI Capital, Inc. the investment manageriFiling they signed
BKBehzad KhosrowshahiMember of Board of Managers of Issuer's general partner: Drug Royalty III GP, LLC (""General Partner"")iFiling they signed
GMGerard MatheisMember of Board of ManagersiFiling they signed
MCM. Craig ShepherdMember of Board of Managers of General PartneriFiling they signed
SSSinan SarMember of Board of ManagersiFiling they signed
WSWilliam ShawMember of Board of Managers of Issuer's general partner: Drug Royalty III GP, LLC (""General Partner"")iFiling they signed
We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.